What is Universal Ibogaine Inc. (IBOGF) stock price today?

Universal Ibogaine Inc. (IBOGF) is currently trading at $0.02, up 6.82% today.

What is IBOGF P/E ratio?

Universal Ibogaine Inc.'s P/E ratio is -0.09. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.

What is IBOGF return on equity (ROE)?

Universal Ibogaine Inc.'s return on equity (ROE) is -304.82%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.

What is Universal Ibogaine Inc.'s market cap?

Universal Ibogaine Inc. has a market capitalization of $7.35M.

OTC · Biotechnology

Universal Ibogaine Inc. (IBOGF) Stock

$0.02 +6.82% OTC: IBOGF Healthcare

Universal Ibogaine Inc., a life sciences enterprise, focuses on developing, acquiring, and operating addiction treatment centers across Canada. The company is additionally preparing to launch clinical trials aimed at researching ibogaine's potential therapeutic applications for addiction.

Valuation

Metric	Value
Price	$0.02
Market Cap	$7.35M
P/E Ratio	-0.09
P/B Ratio	0.24
P/S Ratio	1.46
EPS (TTM)	$-0.06
52-Week High	$0.35
52-Week Low	$0.00
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-304.82%
ROA	-166.14%
ROCE	8.75%
Gross Margin	100.00%
Operating Margin	46.43%
Net Margin	-980.22%
Debt/Equity	0.44
Current Ratio	1.60

Annual Financials (USD)

Metric	2018	2019	2020	2021	2022
Revenue	$0	$0	$0	$0	$1.0M
Operating Profit	$0	$0	$0	$-4.0M	$0
Net Profit	$0	$0	$0	$-4.0M	$-10.0M
EPS	$-0.04	$-0.01	$-0.01	$-0.03	$-0.06
Op Margin	—	—	—	—	46.4%

Balance Sheet (USD)

Metric	2018	2019	2020	2021	2022
Total Assets	$0	$0	$0	$4.0M	$6.0M
Total Liabilities	$0	$0	$0	$1.0M	$2.0M
Cash	$0	$0	$0	$0	$1.0M
Borrowings	$0	$0	$0	$0	$2.0M

Cash Flow (USD)

Metric	2018	2019	2020	2021	2022
Operating Cash Flow	$0	$0	$0	$-3.0M	$-4.0M
Investing Cash Flow	$0	$0	$0	$0	$-2.0M
Financing Cash Flow	$0	$0	$0	$1.0M	$1.0M
Net Cash Flow	$0	$0	$0	$0	$1.0M
Free Cash Flow	$0	$0	$0	$-3.0M	$-4.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	-0.56
FCF Yield	-283.12%
Quick Ratio	1.60
Interest Coverage	7.34
Return 1Y	11.39%
Return 3Y	150.00%
Return 5Y	—

Ownership

Insiders Held13.44%

Institutions Held0.00%

Institutions Float Held0.00%

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
AAGHAmerica Great Health	$0.00	—	1.00	$2.12M	0.00%
ADXSAyala Pharmaceuticals, Inc.	$0.60	+0.00%	-0.08	$25.71M	0.00%
AGNPFGrey Matters Health Inc.	$0.25	-17.12%	-0.43	$869804	0.00%
APLIFAppili Therapeutics Inc	$0.01	+0.00%	-0.44	$1.46M	0.00%
GENPFGenix Pharmaceuticals Corporation	$0.01	+0.00%	-6.45	$844893	0.00%

About Universal Ibogaine Inc.

Universal Ibogaine Inc. is headquartered in CA.

Universal Ibogaine Inc. (IBOGF) stock trades at $0.02 with a market capitalization of $7.35M. The stock is valued at a negative price-to-earnings (P/E) ratio of -0.09, reflecting a net loss over the last twelve months, price-to-book of 0.24, price-to-sales of 1.46. Over the past 52 weeks the stock has ranged between $0.00 and $0.35, and currently trades 94.3% below its 52-week high.

On profitability, Universal Ibogaine Inc. generates a return on equity (ROE) of -304.82% (negative, reflecting a net loss), return on capital employed of 8.75%, an operating margin of 46.43%, a net profit margin of -980.22%.

Official website: universalibogaine.com